Doré, Vincent http://orcid.org/0000-0002-8051-0558
Krishnadas, Natasha
Bourgeat, Pierrick
Huang, Kun
Li, Shenpeng
Burnham, Samantha
Masters, Colin L.
Fripp, Jurgen
Villemagne, Victor L.
Rowe, Christopher C.
Funding for this research was provided by:
National Health and Medical Research Council (APP1132604, APP1140853, APP1152623)
Enigma Australia
Article History
Received: 8 September 2020
Accepted: 2 January 2021
First Online: 26 January 2021
Compliance with ethical standards
:
: Christopher C. Rowe has received research grants from NHMRC, Enigma Australia, Biogen, Eisai, and Abbvie. He is on the scientific advisory board for Cerveau Technologies and Biogen Australia. Victor Villemagne is and has been a consultant or paid speaker at sponsored conference sessions for Eli Lilly, Life Molecular Imaging, GE Healthcare, Abbvie, Lundbeck, Shanghai Green Valley Pharmaceutical Co. Ltd., and Hoffmann La Roche. All the other authors declare that they have no conflict of interest.
: This study was approved by the Austin Health Human Research ethics Committee (HREC/18/Austin/201).
: Given the retrospective nature of the study and the use of anonymized patient data, requirements for informed consent were waived.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.